AIM
MYOK

Alambic Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Alambic Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,600
Closed -$283K – 549
2017
Q3 		$283K Buy
+6,600
New +$211K 0.03% 413

Other funds holding MYOK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Alambic Investment Management's MYOK Position: Q4 2017 in Review

Alambic Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2017, closing a stake of 6,600 shares — an estimated $283K sold.

Alambic Investment Management first reported a position in MYOK in Q3 2017 and held it in 1 quarter. The position peaked at $283K in Q3 2017. 121 funds tracked by Wall St. Rank hold MYOK as of Q4 2017.

  • Alambic Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Alambic Investment Management sold 6,600 MyoKardia, Inc. Common Stock shares in Q4 2017, an estimated $283K.
  • Alambic Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Alambic Investment Management's MyoKardia, Inc. Common Stock position peaked at $283K in Q3 2017.
  • 121 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2017.

Based on Alambic Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.